Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
13. 20
-0.09
-0.68%
$
1.17B Market Cap
- P/E Ratio
- Div Yield
987,350 Volume
- Eps
$ 13.29
Previous Close 
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.23 | 0.07 |
| | | 0.43 | - |
AMLX Earnings Reports FAQ
What is the earnings per share (EPS) for AMLX?
EPS data for AMLX is currently not available, as Amylyx Pharmaceuticals, Inc. Common Stock has not reported recent earnings.
What is the company's earnings growth rate?
Amylyx Pharmaceuticals, Inc. Common Stock has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Amylyx Pharmaceuticals, Inc. Common Stock has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Amylyx Pharmaceuticals, Inc. Common Stock are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AMLX at this time, as Amylyx Pharmaceuticals, Inc. Common Stock has no recent EPS data to calculate it.
